辰欣药业股份有限公司关于公司及控股子公司使用闲置自有资金进行委托理财及证券投资的公告

Core Viewpoint - The company plans to utilize idle funds for entrusted wealth management and securities investment, with a total amount not exceeding RMB 2.9 billion, to enhance the efficiency of fund usage and generate returns for shareholders [2][3][14]. Investment Overview - Investment Purpose: The company aims to improve the efficiency of idle funds while ensuring normal business operations and daily capital needs [3]. - Total Investment Amount: The total investment amount will not exceed RMB 2.9 billion, with RMB 2.3 billion allocated for entrusted wealth management and RMB 600 million for securities investment [2][3][14]. - Investment Duration: The investment period is set for 12 months from the approval date of the board meeting [4][14]. Investment Details - Source of Funds: The funds will come from the company's idle self-owned capital [4]. - Investment Methods: Entrusted wealth management will focus on bank wealth management products, income certificates, and funds, while securities investment will include government bonds, bond repurchase agreements, ETFs, and stocks [4][3]. - Approval Process: The investment plan has been approved by the company's board of directors and does not require shareholder meeting approval [6][14]. Impact on the Company - The use of idle funds for wealth management and securities investment will not affect the company's normal cash flow or operations, and it aims to enhance fund returns and protect shareholder interests [8][14]. - Accounting Treatment: The company will account for the entrusted wealth management and securities investment in accordance with relevant accounting standards, reflecting them in the balance sheet and income statement [8].